- Home
- CYCU vs TLPH Comparison
CYCU vs TLPH Comparison
Compare CYCU & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CYCU | TLPH |
|---|---|---|
| Founded | N/A | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.3M | 70.3M |
| IPO Year | 2021 | 2010 |
Fundamental Metrics
Financial Performance| Metric | CYCU | TLPH |
|---|---|---|
| Price | $2.39 | $1.03 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $3.13 |
| AVG Volume (30 Days) | ★ 128.9K | 55.9K |
| Earning Date | 11-16-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $17,771,485.00 | $2,151,000.00 |
| Revenue This Year | $13.37 | N/A |
| Revenue Next Year | $66.84 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.01 | $0.69 |
| 52 Week High | $15.52 | $1.57 |
Technical Indicators
Market Signals| Indicator | CYCU | TLPH |
|---|---|---|
| Relative Strength Index (RSI) | 45.17 | 43.61 |
| Support Level | $0.03 | $1.03 |
| Resistance Level | $2.77 | $1.14 |
| Average True Range (ATR) | 0.26 | 0.05 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 49.35 | 34.19 |
Price Performance
Historical ComparisonAbout CYCU Cycurion Inc.
Cycurion Inc. provides information technology security solutions through its subsidiaries. The company continually strives to deliver top-notch services in risk management, cybersecurity, information assurance, systems engineering, and help desk solutions. The company has one reportable segment, which is the delivery of products and services in the areas of information technology, electronic warfare, information warfare and cybersecurity in the governmental and commercial markets. The company generates the majority of its revenue from Advisory Consulting services, with small portion revenue generated from Managed Security Service Practice (MSSP) and Software as a Service (Saas).
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.